Dupilumab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Non-Small Cell Lung Cancer. According to GlobalData, Phase II drugs for Non-Small Cell Lung Cancer ...
Amgen and AstraZeneca have said their severe asthma therapy Tezspire could have ... Trends towards improved outcomes were also seen with the drug on lung function scores and patient-reported ...
Dupilumab is under clinical development by Regeneron Pharmaceuticals and currently in Phase III for Bullous Pemphigoid. According to GlobalData, Phase III drugs for Bullous Pemphigoid does not have ...
Feb. 3, 2025 — Long-term exposure to PM2.5, PM10, NO2 and ozone (O3) air pollution is associated with more hospital admissions for lower respiratory tract infections in ... Researchers Identify ...
Lyn Iemma, aged 75 years at the time of writing, would not describe her life as dramatic. Born and raised in Perth, WA, Australia, this thriving but relaxed city is the place she has always called ...
Their analysis shows that children's risk of developing asthma ... Combination Treatment Improves Response to Immunotherapy for Lung Cancer Sep. 25, 2024 — Researchers have tested a combination ...
Read these and more top stories in allergy/asthma below: Dupilumab does not desensitize children with peanut allergy Following receipt of dupilumab for 24 weeks, most children or adolescents with ...
More than five million people in the UK suffer with asthma. Asthma + Lung UK, external have said that humidity and thunderstorms can cause an 'unseasonal spike' in asthma-related A&E visits ...
The SARS-CoV-2 pandemic interrupted much respiratory research. Respiratory clinical academics joined colleagues in providing clinical care, and global research efforts were directed to finding new ...
Asthma, chronic obstructive pulmonary disease (COPD) and lung cancer cause extensive mortality and morbidity worldwide. However, the current state-of-the-art diagnosis and management schemes of ...
Asthma is a chronic lung disease that causes reversible airway narrowing, inflammation in the airways, and mucus production. Some asthma symptoms are shortness of breath, tightening in the chest ...
A systematic review and meta-analysis indicated that omalizumab significantly improved lung function and asthma control while ... switched from mepolizumab to dupilumab experienced significant ...